203 related articles for article (PubMed ID: 24113455)
1. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
[TBL] [Abstract][Full Text] [Related]
2. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
Breitenecker K; Heiden D; Demmer T; Weber G; Primorac AM; Hedrich V; Ortmayr G; Gruenberger T; Starlinger P; Herndler-Brandstetter D; Barozzi I; Mikulits W
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673795
[TBL] [Abstract][Full Text] [Related]
4. Constitutive Notch2 signaling induces hepatic tumors in mice.
Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
[TBL] [Abstract][Full Text] [Related]
5. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
6. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
7. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
8. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.
Meng Z; Wang X; Gan Y; Zhang Y; Zhou H; Ness CV; Wu J; Lou G; Yu H; He C; Xu R; Huang W
J Hepatol; 2012 Nov; 57(5):1004-12. PubMed ID: 22728874
[TBL] [Abstract][Full Text] [Related]
9. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
[TBL] [Abstract][Full Text] [Related]
10. BOK promotes chemical-induced hepatocarcinogenesis in mice.
Rabachini T; Fernandez-Marrero Y; Montani M; Loforese G; Sladky V; He Z; Bachmann D; Wicki S; Villunger A; Stroka D; Kaufmann T
Cell Death Differ; 2018 Mar; 25(4):708-720. PubMed ID: 29229991
[TBL] [Abstract][Full Text] [Related]
11. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN
Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132
[TBL] [Abstract][Full Text] [Related]
12. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
13. Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.
Zhang XF; Tan X; Zeng G; Misse A; Singh S; Kim Y; Klaunig JE; Monga SP
Hepatology; 2010 Sep; 52(3):954-65. PubMed ID: 20583210
[TBL] [Abstract][Full Text] [Related]
14. Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice.
Casagrande V; Mauriello A; Anemona L; Mavilio M; Iuliani G; De Angelis L; D'Onofrio M; Arisi I; Federici M; Menghini R
Acta Diabetol; 2019 Dec; 56(12):1265-1274. PubMed ID: 31292722
[TBL] [Abstract][Full Text] [Related]
15. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats.
Lim IK
Mech Ageing Dev; 2002 Nov; 123(12):1665-80. PubMed ID: 12470904
[TBL] [Abstract][Full Text] [Related]
17. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
[TBL] [Abstract][Full Text] [Related]
18. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
19. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
20. Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma.
Liu C; Ren YF; Dong J; Ke MY; Ma F; Monga SPS; Wu R; Lv Y; Zhang XF
Cancer Lett; 2017 Dec; 410():20-31. PubMed ID: 28942012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
